Core Viewpoint - The company has established a professional asset management team to diversify its investment portfolio and enhance long-term returns while managing risks [1] Group 1: Investment Strategy - The company adopts an asset allocation model inspired by Yale University's endowment fund, focusing on a global perspective for diversified asset management [1] - The core of the asset allocation strategy is to combine low-correlated assets to reduce risk and improve risk-adjusted returns, thereby optimizing the risk-return profile of the investment portfolio [1] Group 2: Asset Composition - As of the end of 2024, the diversified asset portfolio consists of: - Cash assets: 2.2% - Fixed income assets: 65.2% - Public market equities: 19.3% - Private equity: 11.7% - Hedge funds: 1.6% [1] - The fixed income assets primarily include money market funds, fixed income securities, government bonds, credit bonds, and private credit [1] Group 3: Performance Metrics - Investors are encouraged to monitor the fair value changes and investment income in the 2024 annual report for insights into the company's asset performance over the past year [1]

Core Viewpoint - Company reported significant profit growth for the first half of 2025, with net profit expected to be between 880 million to 980 million yuan, representing an increase of 46.24% to 62.86% compared to the same period last year [1] Group 1: Financial Performance - The increase in profit is primarily attributed to the strong performance of the company's asset management business and diversified asset allocation [1] - Investment activities are part of the company's normal operations, with investment income and fair value changes classified as regular gains [1] Group 2: Business Strategy - The company focuses on global diversified asset management to ensure capital preservation and growth, enhancing its risk resistance capabilities [1] - The company's home-use respiratory virus screening products have strong consumer attributes, with ongoing market demand in the consumer sector [1] Group 3: Market Expansion - The company is actively expanding its sales channels, achieving broad coverage in both online and offline retail through platforms like Amazon, CVS, and Walmart [1] - In the home healthcare electronic products sector, the company plans to continuously expand its product lineup, leveraging the brand advantages of iHealth to introduce competitive technologies and products to international markets based on market demand [1]